PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020)

Zhang, Xuan; Tan, Ran; Lam, Wai Ching; Yao, Liang; Wang, Xiaoqin; Cheng, Chung Wah; Liu, Fan; Chan, Jacky C. P.; Aixinjueluo, Qi-Ying; Lau, Chung Tai; Chen, Yaolong; Yang, Kehu; Wu, Taixiang; Lyu, Aiping; Bian, Zhaoxiang

doi:10.1142/s0192415x20500639

Cited by 74 publications

(33 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This scoping review was conducted by using the methodological framework for scoping review outlined by Arksey and O'Malley [41]. It also followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews' guidelines [42].…”

Section: Overviewmentioning

confidence: 99%

What Demographic, Social, and Contextual Factors Influence the Intention to Use COVID-19 Vaccines: A Scoping Review

AlShurman

Khan

Mac

et al. 2021

IJERPH

136

162

View full text Add to dashboard Cite

Background: During the COVID-19 crisis, an apparent growth in vaccine hesitancy has been noticed due to different factors and reasons. Therefore, this scoping review was performed to determine the prevalence of intention to use COVID-19 vaccines among adults aged 18–60, and to identify the demographic, social, and contextual factors that influence the intention to use COVID-19 vaccines. Methods: This scoping review was conducted by using the methodological framework for scoping review outlined by Arksey and O’Malley. A search strategy was carried out on four electronic databases: PubMed, Scopus, CINAHL, and PsycINFO. All peer-reviewed articles published between November 2019 and December 2020 were reviewed. Data were extracted to identify the prevalence of, and factors that influence, the intention to use COVID-19 vaccines. Results: A total of 48 relevant articles were identified for inclusion in the review. Outcomes presented fell into seven themes: demographics, social factors, vaccination beliefs and attitudes, vaccine-related perceptions, health-related perceptions, perceived barriers, and vaccine recommendations. Age, gender, education level, race/ethnicity, vaccine safety and effectiveness, influenza vaccination history, and self-protection from COVID-19 were the most prominent factors associated with intention to use COVID-19 vaccines. Furthermore, the majority of studies (n = 34/48) reported a relatively high prevalence of intention to get vaccinated against COVID-19, with a range from 60% to 93%. Conclusion: This scoping review enables the creation of demographic, social, and contextual constructs associated with intention to vaccinate among the adult population. These factors are likely to play a major role in any targeted vaccination programs, particularly COVID-19 vaccination. Thus, our review suggests focusing on the development of strategies to promote the intention to get vaccinated against COVID-19 and to overcome vaccine hesitancy and refusal. These strategies could include transparent communication, social media engagement, and the initiation of education programs.

show abstract

Section: Overviewmentioning

confidence: 99%

What Demographic, Social, and Contextual Factors Influence the Intention to Use COVID-19 Vaccines: A Scoping Review

AlShurman

Khan

Mac

et al. 2021

IJERPH

136

162

View full text Add to dashboard Cite

show abstract

“…This systematic review and meta-analysis will be reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020). [ 34 ]…”

Section: Methods and Analysismentioning

confidence: 99%

Effectiveness and safety of Chinese herbal formula combined with western medicine for ankylosing spondylitis

Miao¹,

Deng²,

2021

Medicine

View full text Add to dashboard Cite

Background: Ankylosing spondylitis (AS) is a chronic progressive inflammatory disease of the spine, which mainly invades the sacroiliac joint, spine, and large joints near the trunk, leading to fibrous and skeletal ankylosis and deformity, and can cause damage to the eyes, lung, cardiovascular, kidney and other organs. Chinese herbal formulas (CHF) is an important interventions of Traditional Chinese Medicine (TCM), and CHFs combined with western medicine are widely used in clinical practice to treat AS. Methods: Eight databases will be systematically retrieved from their inceptions to March 2021. Only randomized controlled trials (RCTs) of CHFs combined with western medicine for AS treatment will meet the inclusion criteria. The primary outcomes we focus on include clinical effectiveness rate, TCM syndrome score, TCM symptom score, Bath ankylosing spondylitis disease activity index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), chest expansion, nocturnal spinal pain, adverse reactions, erythrocyte sedimentation rate (ESR), and C protein response (CRP). The research screening, data extraction, and risk of bias assessment will be performed independently by 2 researchers, and divergence will be solved by a third researcher. Revman 5.3 software will be used for meta-analysis. The confidence of evidence will be graded using grading of recommendations assessment, development, and evaluation (GRADE) algorithm and methodological quality will be assessed adopting risk of bias in systematic reviews (ROBIS). Results: This systematic review (SR) will provide evidence-based medical evidence for AS therapy by CHF combined with western medicine and we will submit the findings of this SR for peer-review publication. Conclusions: This SR will provide latest and updated summary proof for assessing the effectiveness and safety of CHF combined with western medicine for AS. Registration number: INPLASY 202150089.

show abstract

“…On the other hand, a standardized reporting system of TCM clinical research has been established during the past two decades. This includes the TCM extension of a series of mainstream international reporting standards for the reporting of RCTs, case reports, and SR/MAs, 58–61 as well as expert recommendations for the reporting of a certain TCM intervention 62,63 . This work has greatly improved the quality of TCM research and also increased the possibility that a clinical study could be repeated by futrue researchers 64…”

Section: The Influence Of Evidence‐based Tcm Researchmentioning

confidence: 99%

Evidence‐based traditional Chinese medicine research: Two decades of development, its impact, and breakthrough

Tian

Chen

Zhang

et al. 2021

J Evidence Based Medicine

View full text Add to dashboard Cite

It has been over 20 years since the introduction of evidence‐based medicine (EBM) into the research of traditional Chinese medicine (TCM). The development of evidence‐based TCM research has profoundly influenced the process of clinical research and decision‐making, impelling researchers to pay attention to raise evidence quality, accumulate data, and explore appropriate evaluation methods adaptive to TCM original theories and knowledge. In this paper, the authors aim to summarize and review the existing work and seek promising research interests in this field, expecting to inspire more thoughts leading to breakthroughs in the near future.

show abstract

PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020)

Cited by 74 publications

References 53 publications

What Demographic, Social, and Contextual Factors Influence the Intention to Use COVID-19 Vaccines: A Scoping Review

What Demographic, Social, and Contextual Factors Influence the Intention to Use COVID-19 Vaccines: A Scoping Review

Effectiveness and safety of Chinese herbal formula combined with western medicine for ankylosing spondylitis

Evidence‐based traditional Chinese medicine research: Two decades of development, its impact, and breakthrough

Contact Info

Product

Resources

About